T

Theriva Biologics Inc
F:SFY

Watchlist Manager
Theriva Biologics Inc
F:SFY
Watchlist
Price: 2.42 EUR
Market Cap: 41.8m EUR

Wall Street
Price Targets

SFY Price Targets Summary
Theriva Biologics Inc

Wall Street analysts forecast SFY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SFY is 10.01 EUR with a low forecast of 9.91 EUR and a high forecast of 10.3 EUR.

Lowest
Price Target
9.91 EUR
309% Upside
Average
Price Target
10.01 EUR
314% Upside
Highest
Price Target
10.3 EUR
326% Upside
Theriva Biologics Inc Competitors:
Price Targets
DSGN
Design Therapeutics Inc
71% Upside
096530
Seegene Inc
60% Upside
MRUS
Merus NV
125% Upside
145020
Hugel Inc
55% Upside
MSB
Mesoblast Ltd
39% Downside
ARMP
Armata Pharmaceuticals Inc
247% Upside
4893
Noile-Immune Biotech Inc
135% Upside
AZT
Arcticzymes Technologies ASA
27% Upside

Revenue
Forecast

Revenue Estimate
Theriva Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Theriva Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Theriva Biologics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-98%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SFY's stock price target?
Price Target
10.01 EUR

According to Wall Street analysts, the average 1-year price target for SFY is 10.01 EUR with a low forecast of 9.91 EUR and a high forecast of 10.3 EUR.

Back to Top